USD 0.17
(8.57%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -11.87 Million USD | -124.91% |
2022 | -3.51 Million USD | -32.0% |
2021 | -1.51 Million USD | -27.24% |
2020 | -2.34 Million USD | 14.56% |
2019 | -2.09 Million USD | 38.72% |
2018 | -4.55 Million USD | -131.84% |
2017 | -1.96 Million USD | 0.0% |
2014 | -3.3 Million USD | 54.65% |
2013 | 3.18 Million USD | -250.38% |
2012 | -6.78 Million USD | -104.37% |
2011 | -2.78 Million USD | 56.16% |
2010 | -4.23 Million USD | 52.31% |
2009 | -4.92 Million USD | 16.78% |
2008 | -5.66 Million USD | -31.74% |
2007 | -5.56 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -6.7 Million USD | -296.97% |
2024 Q1 | -2.3 Million USD | 64.42% |
2023 FY | - USD | -124.91% |
2023 Q3 | -2.47 Million USD | -15.3% |
2023 Q4 | -4.01 Million USD | -62.51% |
2023 Q2 | -2.14 Million USD | -87.81% |
2023 Q1 | -1.14 Million USD | -0.8% |
2022 Q2 | -957.69 Thousand USD | -2.89% |
2022 Q1 | -930.77 Thousand USD | 58.74% |
2022 FY | - USD | -32.0% |
2022 Q4 | -1.13 Million USD | -26.07% |
2022 Q3 | -898.83 Thousand USD | 6.15% |
2021 Q2 | -290.22 Thousand USD | 26.04% |
2021 Q1 | -392.42 Thousand USD | 49.23% |
2021 FY | - USD | -27.24% |
2021 Q4 | -2.25 Million USD | -474.31% |
2021 Q3 | -392.77 Thousand USD | -35.34% |
2020 Q4 | -773 Thousand USD | -57.76% |
2020 Q2 | -598 Thousand USD | -14.56% |
2020 FY | - USD | 14.56% |
2020 Q1 | -522 Thousand USD | 49.9% |
2020 Q3 | -490 Thousand USD | 18.06% |
2019 Q1 | -605 Thousand USD | -15.24% |
2019 Q3 | -599 Thousand USD | -10.72% |
2019 Q4 | -1.04 Million USD | -73.96% |
2019 FY | - USD | 38.72% |
2019 Q2 | -541 Thousand USD | 10.58% |
2018 Q1 | -2.14 Million USD | -116.34% |
2018 Q4 | -525 Thousand USD | -14.88% |
2018 Q3 | -457 Thousand USD | 67.88% |
2018 Q2 | -1.42 Million USD | 33.66% |
2018 FY | - USD | -131.84% |
2017 Q4 | -991.5 Thousand USD | -117.43% |
2017 Q2 | -545 Thousand USD | 3.8% |
2017 Q1 | -566.5 Thousand USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q3 | -456 Thousand USD | 16.33% |
2015 Q1 | -805.75 Thousand USD | -11.62% |
2014 FY | - USD | 54.65% |
2014 Q2 | -1.79 Million USD | -851.75% |
2014 Q1 | -188.65 Thousand USD | 72.38% |
2014 Q4 | -721.85 Thousand USD | 47.47% |
2014 Q3 | -1.37 Million USD | 23.46% |
2013 Q3 | -641.88 Thousand USD | -1483.91% |
2013 Q4 | -683.03 Thousand USD | -6.41% |
2013 FY | - USD | -250.38% |
2013 Q1 | -5.79 Million USD | -776.11% |
2013 Q2 | -40.52 Thousand USD | 99.3% |
2012 Q3 | -396.12 Thousand USD | 71.07% |
2012 Q4 | -661.4 Thousand USD | -66.97% |
2012 FY | - USD | -104.37% |
2012 Q1 | -267.15 Thousand USD | -1.7% |
2012 Q2 | -1.36 Million USD | -412.53% |
2011 Q3 | -183.51 Thousand USD | -173.46% |
2011 Q1 | -343.76 Thousand USD | 1.43% |
2011 Q4 | -262.67 Thousand USD | -43.14% |
2011 Q2 | 249.8 Thousand USD | 172.67% |
2011 FY | - USD | 56.16% |
2010 FY | - USD | 52.31% |
2010 Q2 | -459.77 Thousand USD | 51.58% |
2010 Q1 | -949.48 Thousand USD | -391.91% |
2010 Q4 | -348.74 Thousand USD | 47.78% |
2010 Q3 | -667.81 Thousand USD | -45.25% |
2009 Q4 | -193.02 Thousand USD | 88.55% |
2009 FY | - USD | 16.78% |
2009 Q3 | -1.68 Million USD | 51.22% |
2009 Q2 | -3.45 Million USD | -635.6% |
2009 Q1 | -469.8 Thousand USD | -7.82% |
2008 Q4 | -435.75 Thousand USD | 24.6% |
2008 Q3 | -577.89 Thousand USD | 79.51% |
2008 Q1 | -707.06 Thousand USD | 80.26% |
2008 Q2 | -2.82 Million USD | -298.92% |
2008 FY | - USD | -31.74% |
2007 Q2 | -2.11 Million USD | -145.74% |
2007 Q3 | -1.12 Million USD | 47.14% |
2007 FY | - USD | 0.0% |
2007 Q4 | -3.58 Million USD | -219.67% |
2007 Q1 | -862.62 Thousand USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Achiko AG | -8.32 Million USD | -42.684% |
Accelera Innovations, Inc | - USD | Infinity% |
Aspyra Inc. | -2.84 Million USD | -317.355% |
Cannabis Sativa, Inc. | -1.11 Million USD | -965.863% |
CompuMed, Inc. | 690.19 Thousand USD | 1821.174% |
CompuGroup Medical SE & Co. KGaA | 212.78 Million USD | 105.583% |
Cogstate Limited | 9.89 Million USD | 220.1% |
CareView Communications, Inc. | -210.04 Thousand USD | -5555.749% |
Craneware plc | 54.26 Million USD | 121.893% |
Caduceus Software Systems Corp. | -12.29 Million USD | 3.361% |
Certive Solutions Inc. | -704.66 Thousand USD | -1585.823% |
Drug Free Solution, Inc. | -1.39 Million USD | -751.614% |
DATATRAK International, Inc. | 2.72 Million USD | 535.373% |
Strainsforpains, Inc. | -65.61 Thousand USD | -18006.068% |
Healixa Inc. | -6.32 Million USD | -87.955% |
Easy Technologies Inc. | - USD | Infinity% |
eWellness Healthcare Corporation | - USD | Infinity% |
Founders Bay Holdings | 10.16 Million USD | 216.824% |
Health Discovery Corporation | - USD | Infinity% |
Healthcare Integrated Technologies, Inc. | -425.48 Thousand USD | -2691.945% |
H-Source Holdings Ltd. | - USD | Infinity% |
InterCare DX, Inc. | - USD | Infinity% |
IQ-AI Limited | -370.35 Thousand USD | -3107.586% |
Cannabiz Mobile, Inc. | -750.00 USD | -1583818.8% |
Mednow Inc. | -28.12 Million USD | 57.76% |
Galileo Life Sciences, Inc. | -270.72 Thousand USD | -4288.024% |
MediXall Group, Inc. | -6.52 Million USD | -82.099% |
Mitesco, Inc. | -11.96 Million USD | 0.702% |
MobileSmith, Inc. | -13.83 Million USD | 14.151% |
NantHealth, Inc. | -38.53 Million USD | 69.172% |
Net Medical Xpress Solutions, Inc. | -1.69 Million USD | -599.611% |
OneLife Technologies Corp. | - USD | Infinity% |
ORHub, Inc. | -12.08 Million USD | 1.715% |
Patient Access Solutions, Inc. | -12.09 Million USD | 1.81% |
Pharma-Bio Serv, Inc. | 1.31 Million USD | 1005.626% |
PPJ Healthcare Enterprises, Inc. | 74.73 Thousand USD | 15996.415% |
Medical Cannabis Payment Solutions, Inc. | -12.18 Thousand USD | -97399.926% |
Renalytix Plc | -28.52 Million USD | 58.349% |
Revium Recovery Inc. | -678 Thousand USD | -1652.123% |
RYAH Group, Inc. | - USD | Infinity% |
Carepay Inc. | -369.00 USD | -3219247.154% |
Vaso Corporation | 4.19 Million USD | 383.18% |
Vynleads, Inc. | -235.72 Thousand USD | -4939.491% |